Stock listing
Psyence Biomedical Ltd.
Selected listing: PBM · NASDAQ · USD · US
Psyence Biomedical Ltd. (NASDAQ:PBM), Health Technology. Latest release Oct 5, 2026: Psyence BioMed Partners with DEA-Registered Benuvia Operations…
- Ticker
- NASDAQ:PBM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Psyence Biomedical Ltd.
Psyence Biomedical Ltd. is a public company traded under the ticker PBM in the American market. Psyence focuses on the development of psychedelic therapies and related products.
Latest news from Psyence Biomedical Ltd.
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
October 4, 2026
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
September 28, 2026
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
May 15, 2026
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
April 23, 2026
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
April 19, 2026
Research Psyence Biomedical Ltd.
Psyence Biomedical Ltd. company profile
View the public company page for Psyence Biomedical Ltd. on 6ix.
Psyence Biomedical Ltd. news
Read company news and market updates connected to Psyence Biomedical Ltd..
Psyence Biomedical Ltd. investor events
Find investor webinars, events, and replay context for Psyence Biomedical Ltd..